Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 368141 - 368160 out of 498614 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Romania (legislatie) | (L01FG02) ramucirumab | CYRAMZA | Ambalaj cu 2 flacoane a 10ml,CONC. PT. SOL. PERF., 10 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | ELILILLYNEDERLANDBV |
| Romania (legislatie) | (L01FX02) gemtuzumab ozogamicin | MYLOTARG 5 mg | Cutie cu 1 flac. din sticla bruna cu dop din cauciuc butilic si sigiliu cu capac detasabil x5 mg gemtuzumab ozogamicin (5 ani; Dupa reconstituire - se utilizeaza imediat),PULB. PT. CONC. PT.SOL. PERF., 5 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PFIZEREUROPEMAEEIG |
| Romania (legislatie) | (L01FX04) ipilimumab | YERVOY 5 mg/ml | Cutie cu 1flacon din sticla x 40 ml concentrat pt. sol. perf. (200 mg ipilimumab) (3 ani),CONC.PT. SOL. PERF., 5mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
| Romania (legislatie) | (L01FX04) ipilimumab | YERVOY 5 mg/ml | Cutie cu 1 flacon din sticla x 10 ml concentrat pt. sol. perf. (50mg ipilimumab) (3 ani),CONC.PT. SOL. PERF., 5mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
| Romania (legislatie) | (L01FX04) ipilimumab | ZANOCIN 200 mg | Cutie cu 1 blist. PVC/Al x 10 compr. film.,COMPR. FILM., 200mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | TERAPIAS.A. |
| Romania (legislatie) | (L01FX05) brentuximab vedotin | ADCETRIS 50 mg | Cutie cu 1 flacon x 50 mg pulbere pentru concentrat pentru soluție perfuzabila,PULB. PT. CONC. PT. SOL. PERF., 50 mg | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TAKEDAPHARMAA/S |
| Romania (legislatie) | (L01FX06) dinutuximab beta | QARZIBA4,5 mg/ml | Cutie cu 1 flac. din sticla, prevăzut cu dop din cauciuc si sigiliu detașabil din Al x4,5 ml conc. pt. sol. perf. (20 mg dinutuximab beta) (3 ani; Dupa deschiderea flac. - se utilizeaza imediat),CONC. PT. SOL. PERF., 4,5 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Neuroblastoma | EUSAPHARMA(NETHERLANDS)B.V. |
| Romania (legislatie) | (L01FX06) dinutuximab beta | QARZIBA4,5 mg/ml | Cutie cu 1 flac. din sticla, prevăzut cu dop din cauciuc si sigiliu detașabil din Al x4,5 ml conc. pt. sol. perf. (20 mg dinutuximab beta) (3 ani; Dupa deschiderea flac. - se utilizeaza imediat),CONC. PT. SOL. PERF., 4,5 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Neuroblastoma | RECORDATINETHERLANDSB.V. |
| Romania (legislatie) | (L01FX07) blinatumomab | BLINCYTO 38,5 micrograme | Ambalaj cu 1 flac. cu pulb. pt. conc. pt. sol. perf. x 38,5 micrograme +1 flac. cu soluție stabilizata x 10 ml,PULB. PT. CONC. SI SOL. PT. SOL. PERF., 38,5 micrograme | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AMGENEUROPEB.V. |
| Romania (legislatie) | (L01FX09) mogamulizumab | POTELIGEO 4 mg/ml | Cutie cu 1 flac. a 5 ml conc. pt. sol. perf. (3 ani-flacon nedeschis),CONC. PT. SOL. PERF., 4mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Sezary Syndrome;Mycosis Fungoides | KYOWAKIRINHOLDINGSB.V. |
| Romania (legislatie) | (L01FX12) tafasitamab | MINJUVI 200 mg | Cutie cu 1flac. din sticla continând 200 mg tafasitamab (4 ani),PULB. PT.CONC. PT. SOL. PERF., 200 mg | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | INCYTEBIOSCIENCESDISTRIBUTIONB.V.-TARILEDEJOS |
| Romania (legislatie) | (L01FX14) polatuzumab vedotin | POLIVY 140 mg | Cutie cu un flacon din sticla de 20 ml conținând 140 mg polatuzumab vedotin,PULB. PT. CONC. PT. SOL. PERF., 20 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FX14) polatuzumab vedotin | POLIVY 30 mg | Cutie cu un flacon din sticla de 6ml conținând 30 mg polatuzumab vedotin,PULB. PT. CONC. PT. SOL. PERF., 20 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FX17) sacituzumab govitecan | TRODELVY 200mg | Cutie cu 1 flac. din sticla transparenta incolora, de 50 ml care contine 200 mg de sacituzumab govitecan,PULB. PT.CONC. PT. SOL. PERF., 200mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GILEADSCIENCESIRELANDUC |
| Romania (legislatie) | (L01FX18) amivantamab | RYBREVANT350 mg | Cutie cu 1flac. din sticla x 7ml conc. (conține 350 mg amivantamab) (24 luni),CONC.PT. SOL. PERF., 350mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | JANSSEN-CILAGINTERNATIONALNV-BELGIA |
| Romania (legislatie) | (L01FX20) tremelimumab | IMJUDO 20 mg/ml | 1 flacon de 15 ml conc. pt. sol. perf.,CONC. PT. SOL. PERF., 20 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB-SUEDIA |
| Romania (legislatie) | (L01FX24) teclistamab | TECVAYLI 10 mg/ml | Cutie cu 1 flac.x3 ml sol.inj. (18 luni-flacon nedeschis),SOL. INJ., 10mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERNATIONALNV |
| Romania (legislatie) | (L01FX24) teclistamab | TECVAYLI 90mg/ml | Cutie cu 1 flac. x 1,7 ml sol. inj (18 luni-flacon nedeschis),SOL. INJ., 90mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERNATIONALNV |
| Romania (legislatie) | (L01FX25) mosunetuzumab | LUNSUMIO 1 mg | Flacon din sticla de tip I cu dop din cauciuc butilic si sigiliu din aluminiu cu un capac detatabil din plastic de culoare gri închis, care contine 1 mg de concentrat pentru solutie perfuzabila (2 ani),CONC. PT. SOL. PERF., 1mg | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH-GERMANIA |
| Romania (legislatie) | (L01FX25) mosunetuzumab | LUNSUMIO 30 mg | Flacon din sticla de tip I cu dop din cauciuc butilic si sigiliu din aluminiu cu un capac detatabil din plastic de culoare albastru deschis, care contine 30 mg de concentrat pentru solutie perfuzabila (2 ani),CONC.PT. SOL. PERF., 30 mg | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH-GERMANIA |
Pages
